Audio Medica - Page 10 of 81 - Interviews with the world’s key opinion leaders in cancer

Interviews with the world’s key opinion leaders in cancer

Rachel E. Rau, Seattle Children's Hospital

Adding a Bi-Specific T-Cell Engager Brings Striking Benefit in Childhood Acute Lymphoblastic Leukemia

December 17, 2024

Audio Journal of Oncology Podcast Adding a Bi-Specific T-Cell Engager Brings Striking Benefit in Childhood Acute Lymphoblastic Leukemia...

Play episode

Double-Edged CAR-T Therapy Improves Survival with Relapsed/Refractory Chronic Lymphoblastic Leukemia

December 9, 2024

Audio Journal of Oncology Podcast Double-Edged CAR-T Therapy Improves Survival with Relapsed/Refractory Chronic Lymphoblastic Leukemia Play...

Play episode

Low Rates of Early Detection Drive Excess Breast Cancer Mortality in Underserved Communities

April 26, 2023

BRIGHTON, UK—In underserved communities throughout the world low rates of early breast cancer detection are key drivers of mortality...

Play episode

Amy A. Kirkwood MSc: Options Identified for Chemotherapy Intensity Reduction in Acute Lymphoblastic Leukemia

February 13, 2023

Audio Journal of Oncology, February 14 2023, Reporting from the American Society of Hematology Annual Meeting (ASH), December 2022 An...

Play episode

Matthias Stelljes MD: Don’t Delay Stem Cell Transplant For Patients with Relapsed or Refractory Acute Myeloid Leukemia

January 23, 2023

Interview with Matthias Stelljes MD, Head of the Allogeneic Stem Cell Program at the University of MÃ¼nster, Germany NEW ORLEANS, USA—For...

Play episode

AUDIO JOURNAL OF ONCOLOGY—Ibrutinib Enables Transplant-Free Therapy for Mantle Cell Lymphoma

January 20, 2023

Audio Journal of Oncology Podcast AUDIO JOURNAL OF ONCOLOGY—Ibrutinib Enables Transplant-Free Therapy for Mantle Cell Lymphoma Play...

Play episode

AUDIO JOURNAL OF ONCOLOGY—Fast Durable Responses to Bi-Specific Antibody Therapy In Heavily Pre-Treated Multiple Myeloma

January 9, 2023

Audio Journal of Oncology Podcast AUDIO JOURNAL OF ONCOLOGY—Fast Durable Responses to Bi-Specific Antibody Therapy In Heavily Pre...

Play episode

AUDIO JOURNAL OF ONCOLOGY—High Response Rates in Lung Cancer from Next Generation ROS1 Inhibitor

January 6, 2023

Audio Journal of Oncology Podcast AUDIO JOURNAL OF ONCOLOGY—High Response Rates in Lung Cancer from Next Generation ROS1 Inhibitor ...

Play episode

AUDIO JOURNAL OF ONCOLOGY – ARROS-1 Study Finds ROS1 Tyrosine Kinase Inhibitor Has Promise as a Tumor Agnostic Therapy

January 5, 2023

Audio Journal of Oncology Podcast AUDIO JOURNAL OF ONCOLOGY - ARROS-1 Study Finds ROS1 Tyrosine Kinase Inhibitor Has Promise as a Tumor...

Play episode

AUDIO JOURNAL OF ONCOLOGY—Pan-AKT Inhibitor Tumor Agnostic Targeting was Safe and Effective in Phase One Study

January 4, 2023

Audio Journal of Oncology Podcast AUDIO JOURNAL OF ONCOLOGY—Pan-AKT Inhibitor Tumor Agnostic Targeting was Safe and Effective in...

Play episode

AUDIO JOURNAL OF ONCOLOGY—MYC-Targeted Drug Had Excellent Safety And Solid Tumor Responses

December 2, 2022

Audio Journal of Oncology Podcast AUDIO JOURNAL OF ONCOLOGY—MYC-Targeted Drug Had Excellent Safety And Solid Tumor Responses Play...

Play episode

Maria Reig MD PhD; ENA 2022 BARCELONA: AUDIO JOURNAL OF ONCOLOGY: ”New Molecular Drug has Clinical Activity in Hepatocellular Carcinoma

November 11, 2022

Audio Journal of Oncology Podcast Maria Reig MD PhD; ENA 2022 BARCELONA: AUDIO JOURNAL OF ONCOLOGY: ”New Molecular Drug has Clinical...

Play episode

Menu